$XAGE

Longevity Health Holdings, Inc.

0
1
0

No SEC Form 4 filings for $XAGE in the last 30 days.

See all $XAGE insider activity →
Low

Longevity Health Holdings, Inc. (XAGE): Entry into a Material Definitive Agreement

Longevity Health Holdings, Inc. (XAGE) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement The Purchase Agreement and the Note On August 31, 2026, Longevity Health Holdings, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Puritan Partners LLC (“Puritan”), an existing

Longevity Health Holdings, Inc. (XAGE): Entry into a Material Definitive Agreement

Longevity Health Holdings, Inc. (XAGE) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement. On August 13, 2026, Longevity Health Holdings, Inc. (the “Company”) and its subsidiary Carmell Regen Med Corporation (“Carmell Regen”) entered into a Settlement Agreement (the “Settlement Agreement”) with Puritan Partners LLC

XAGE sentiment & insider activity

Over the past 7 days, alphai's AI scored 1 news story mentioning XAGE (Longevity Health Holdings, Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.

Recent XAGE coverage spans financial news and corporate actions.

What's driving XAGE

  • The note adds debt and potential dilution of up to ~2.7 M shares, affecting leverage and share count.

    SEC EDGAR 8-K · Sep 4, 2026

  • The 8-K discloses a new secured debt issuance and related amendments/assumptions, which can change near-term leverage, liquidity risk, and covenant/financing expectations.

    SEC EDGAR 8-K · Aug 14, 2026

  • The announcement of an investigation by a class action firm suggests potential legal and financial risks for Longevity Health Holdings, Inc. However, the low relevance score and neutral market sentiment imply limited immediate trading impact.

    Benzinga · Jul 17, 2025

  • Longevity Health Holdings (XAGE) is surging following news of a merger with True Health, a plasma collection company. The merger could enhance revenue streams and market position.

    Benzinga · Jul 15, 2025

  • XAGE experienced a substantial after-hours surge of approximately 60%, driven by positive market sentiment surrounding the merger.

    Benzinga · Jul 15, 2025

alphai scores every news story that mentions XAGE with an AI model for sentiment and relevance, and aggregates insider trades from Longevity Health Holdings, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $XAGE

Score

Longevity Health Holdings, Inc. (XAGE): Entry into a Material Definitive Agreement

Longevity Health Holdings, Inc. (XAGE) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement The Purchase Agreement and the Note On August 31, 2026, Longevity Health Holdings, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Puritan Partners LLC (“Puritan”), an existing

$XAGEMed

Longevity Health Holdings, Inc. (XAGE): Entry into a Material Definitive Agreement

Longevity Health Holdings, Inc. (XAGE) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement. On August 13, 2026, Longevity Health Holdings, Inc. (the “Company”) and its subsidiary Carmell Regen Med Corporation (“Carmell Regen”) entered into a Settlement Agreement (the “Settlement Agreement”) with Puritan Partners LLC

Related tickers